The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.
Sara Sefton
Advertisement
Sara Sefton is technical manager, pharmaceutical development, Vectura.
Articles by Sara Sefton
Advertisement
Latest Updated Articles
Integrated Approach Facilitates Inhalation Drug DevelopmentAugust 1st 2021
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
2
Meeting Tomorrow's Market Requirements: Vetter's Perspective on the Future of Fill & Finish
3
Why Drug Shortages Average 5+ Years: PharmTech Explained
4
ADCs, Degraders, Agonists: 4 Deals CMC Teams Should Track
5